Stock Updates

IDEXX Laboratories, Inc. (NASDAQ: IDXX) – Is this large market cap stock undervalued?

IDEXX Laboratories, Inc. (NASDAQ: IDXX), is firmly in the large market cap category with market cap of 10036.04. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for IDEXX Laboratories, Inc. is 110.79 (with a change from open of -0.20%), this in conjunction with a target price of 116.8. Volume today has so far reached 264441, with an average volume of about 489.36. The GAP for this stock, is -0.64%.

The P/E ratio is 50.58, bringing the forward P/E to a value of 41.49. The current EPS for IDEXX Laboratories, Inc., is 2.21, with a EPS growth for this year coming to a value of 14.40%. Performance has been interesting with performance year to date coming to 53.22%.

Looking further into the growth statistics for IDEXX Laboratories, Inc., EPS is looking like it will grow 14.06% in the next year. Looking even further it is projected to be 14.35%. Quarter over quarter is 22.60% for EPS growth and for sales growth quarter over quarter it is 12.90%. Looking at past EPS growth statistics we see that for the past five years it has been 11.60%. Sales growth for the past five years has in fact been 7.70%.

Looking at the ownership, we see that the insider ownership is at 1.30% and institutional ownership is 94.90%. Shares outstanding is 89.82, while shares float is at a value of 88.25. Float short for IDEXX Laboratories, Inc. is 4.23% and the short ratio is 7.64.

In terms of debt, long term debt/equity is *TBA, while the total debt/equity comes to *TBA. The ability to meet these debts, means that the current ratio is 1, and the quick ratio is 0.8. The most recent gross margin is 55.00% and their operating margin is 18.70%. The profit margin is 11.90%.

IDEXX Laboratories, Inc. has seen returns on assets of 13.60%, and on investment, 22.10%. Return on equity is -392.60%. Price/Earnings to growth ratio is 3.52. Price/Sales ratio is at a value of 5.94, with Price/book ratio coming to *TBA and Price/cash is 27.11, and finally Price/Free cash Flow is 47.54.

The simple moving averages are -0.70% and 24.74% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -5.98% and the 52 week low is 74.53%.

IDEXX Laboratories, Inc. has a dividend yield of *TBA, with a current price of 110.79. The ability to pay this means the payout ratio is 0.00%. This is in an industry, Diagnostic Substances, with equally high dividends from other companies in this sector, which it is Healthcare. IDEXX Laboratories, Inc. is based in USA.

Performance in the Diagnostic Substances industry means that IDEXX Laboratories, Inc. has seen performance for the past week of -1.05%, with performance for the month coming to 3.29%. Looking at the data for the quarter it is at a value of 19.87%, and for the half year the performance is 53.60%. Volatility for this week is 2.35% and for the month this is 1.69%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment